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Mutations in HOXD13 Underlie Syndactyly Type V and a Novel
Brachydactyly-Syndactyly Syndrome
Xiuli Zhao,* Miao Sun,* Jin Zhao, J. Alfonso Leyva, Hongwen Zhu, Wei Yang, Xuan Zeng, Yang Ao,
Qing Liu, Guoyang Liu, Wilson H. Y. Lo, Ethylin Wang Jabs, L. Mario Amzel,
Xiangnian Shan, and Xue Zhang
HOXD13, the homeobox-containing gene located at the most 5′ end of the HOXD cluster, plays a critical role in limb
development. It has been shown that mutations in human HOXD13 can give rise to limb malformations, with variable
expressivity and a wide spectrum of clinical manifestations. Polyalanine expansions in HOXD13 cause synpolydactyly,
whereas amino acid substitutions in the homeodomain are associated with brachydactyly types D and E. We describe
two large Han Chinese families with different limb malformations, one with syndactyly type V and the other with limb
features overlapping brachydactyly types A4, D, and E and mild syndactyly of toes 2 and 3. Two-point linkage analysis
showed LOD scores 13 ( ) for markers within and/or flanking the HOXD13 locus in both families. In the familyvp 0
with syndactyly type V, we identified a missense mutation in the HOXD13 homeodomain, c.950ArG (p.Q317R), which
leads to substitution of the highly conserved glutamine that is important for DNA-binding specificity and affinity. In
the family with complex brachydactyly and syndactyly, we detected a deletion of 21 bp in the imperfect GCN (where
N denotes A, C, G, or T) triplet-containing exon 1 of HOXD13, which results in a polyalanine contraction of seven
residues. Moreover, we found that the mutant HOXD13 with the p.Q317R substitution was unable to transactivate the
human EPHA7 promoter. Molecular modeling data supported these experimental results. The calculated interactions
energies were in agreement with the measured changes of the activity. Our data established the link between HOXD13
and two additional limb phenotypes—syndactyly type V and brachydactyly type A4—and demonstrated that a poly-
alanine contraction in HOXD13, most likely, led to other digital anomalies but not to synpolydactyly. We suggest the
term “HOXD13 limb morphopathies” for the spectrum of limb disorders caused by HOXD13 mutations.
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The homeobox-containing (HOX) genes are a highly con-
served transcription-factor family that displays important
function in early development.1,2 In humans, there are 39
HOX genes arranged in four separate clusters: HOXA, HOXB,
HOXC, and HOXD.3 These clusters are located on chro-
mosomes 7p15, 17q21, 12q13, and 2q31, respectively, and
show a striking colinearity in their 5′r3′ genomic position
and transcription direction. HOXD13 (MIM *142989; Gen-
Bank accession number NM_000523), the most 5′ gene of
the HOXD cluster, has two coding exons: exon 1 with the
imperfect GCN (where N denotes A, C, G, or T) triplet
repeats encoding the N-terminal region with a 15-residue
polyalanine tract (residues 49–63), and exon 2, which con-
tains the homeobox region encoding the C-terminal por-
tion with a 60-residue homeodomain (residues 268–327).4
The homeodomain forms three a-helices. Structural stud-
ies of HOX proteins have shown that residues in the rec-
ognition helix-3—mainly, the 47th isoleucine (I47), the
50th glutamine (Q50), and the 51st asparagine (N51) of
the homeodomain—make base-specific DNA contacts in
the major groove, and residues in the N-terminal arm in-
teract with the minor groove of DNA, thereby collabora-
tively determining DNA-binding specificity and affinity.5–10
HOXD13 is the first HOX gene known to be linked to
human developmental disorders.11,12 Mutations in HOXD13
are associated with limb deformities in both humans and
mice, suggesting a critical role in limb development. Syn-
polydactyly (SPD [MIM 186000], or syndactyly type II) is
a dominantly inherited limb malformation with incom-
plete penetrance and variable expressivity. It is character-
ized by soft-tissue syndactyly between fingers 3 and 4 and
between toes 4 and 5, with partial or complete digit du-
plication within the syndactylous web. Both interfamilial
and intrafamilial variations in SPD limb phenotype exist.
Individuals with an atypical form of SPD share a distinc-
tive set of foot phenotypes, including small spurs of bone
between metatarsals 1 and 2.11 Polyalanine-expansionmu-
tations in HOXD13 lead to typical SPD, whereas deletions
and missense mutations are associated with atypical SPD.11–
21 Furthermore, in the spontaneous spdh mouse mutant,
which has a phenotype similar to human SPD, a polyala-
nine expansion of seven residues in Hoxd13 was de-
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tected.22,23 Missense mutations in HOXD13 also underlie
brachydactyly types D (BDD [MIM 113200]) and E (BDE
[MIM 113300]).24,25 BDD presents with short and broad
distal phalanges of the thumbs and halluces, whereas BDE
has the cardinal feature of one or more shortened meta-
carpals and/or metatarsals. Two HOXD13 missense muta-
tions within the homeodomain—p.S308C and p.I314L—
have been described in families exhibiting features of BDE
with BDD and BDE with mild SPD, respectively.24,25
Syndactyly type V (MIM 186300), defined as “syndac-
tyly associated with metacarpal and metatarsal synostosis”
by Temtamy and McKusick,26(p302) represents one of the
rarest types of nonsyndromic syndactyly.27 It is inherited
as an autosomal dominant trait with synostotic fusion of
metacarpals 4 and 5 as the hallmark.28 Brachydactyly type
A4 (BDA4 [MIM 112800]) is characterized by short middle
phalanges of the 2nd and 5th fingers and absence of mid-
dle phalanges of the 2nd–5th toes. In this report, we de-
scribe limb phenotypes of syndactyly type V and a novel
brachydactyly-syndactyly syndrome that includes BDA4,
and we report novel mutations in HOXD13 in two large
Han Chinese families.
Clinical findings.—We investigated two large Han Chi-
nese families with distinctive limb malformations. Both
families had affected females and male-to-male transmis-
sion (fig. 1A and 1B), consistent with autosomal dominant
inheritance. There were 23 affected individuals in the 6
generations of family 1 (fig. 1A). At the proband’s request,
13 affected individuals were physically examined, and dig-
ital photographs were taken. Among those individuals, 11
had hand and foot radiographs. On radiological exami-
nation, nine affected individuals had bilateral or unilateral
fusion of metacarpals 4 and 5 (fig. 2B, 2F, 2J, and 2N).
Radiographs showed that the fusion was variable in ex-
tent. The proband had a complete fusion in his right hand
(fig. 2B), and eight other affected individuals had bilateral
complete fusion (fig. 2F, 2J, and 2N). In five affected in-
dividuals, the fusion extended to the phalanges of fingers
4 and 5 (fig. 2N). Other hand deformities included ulnar
deviation of fingers 2–5 (12 of 13 subjects), lobster claw–
like or Y-shaped fingers 4 and 5 with an angulated 5th
finger (8 of 13), shortening or clinodactyly of the 5th fin-
gers (3 of 13), short distal phalanges of between one and
all fingers (12 of 13), shortening of fused metacarpals 4
and 5 or metacarpal 5 (6 of 13), unilateral cutaneous syn-
dactyly of fingers 3 and 4 (4 of 13), interdigital clefts be-
tween fingers 3 and 4 (10 of 13), camptodactyly (10 of
13), and absence of distal interphalangeal creases (13 of
13) (fig. 2A, 2B, 2E, 2F, 2I, 2J, 2M, and 2N). None of the
affected individuals had metatarsal fusion of the feet (fig.
2D, 2H, 2L, and 2P). The most constant foot deformities
were varus deviation of the first metatarsals; valgus devia-
tion of toes 1–4; hyperplasia of the 1st ray, affecting the
first metatarsals and the phalanges of the halluces; hypo-
plasia and shortness of metatarsals 2–5; and shortened and
tucked 5th toes (fig. 2C, 2D, 2G, 2H, 2K, 2L, 2O, and 2P).
Mild cutaneous syndactyly of toes 2 and 3 or 3 and 4 was
observed in four affected individuals (IV-5, IV-8, IV-10, and
V-13) (fig. 2K). Of note, one affected individual (V-9) with
bilateral complete fusion of metacarpals 4 and 5 also had
postaxial polydactyly in his left hand, as well as hypospa-
dias. Taken together, the phenotypes in this family closely
resemble the syndactyly type V reported by Robinow and
colleagues.28
Family 2 also had 23 affected individuals in 6 genera-
tions (fig. 1B). All 17 patients who are still alive were avail-
able for phenotype evaluation. Digital photographs and
radiographs were taken for 16 and 13 of them, respec-
tively. On clinical examination, most of the patients ex-
hibited generalized shortening of hands and feet, 11 dis-
played broad and short distal phalanges of the thumbs
(fig. 3A, 3E, 3I, and 3M), and 14 had mild cutaneous syn-
dactyly of toes 2 and 3 (fig. 3C, 3G, 3K, and 3O). Radio-
graphs revealed a constant phenotypic feature in all 13
patients: absence of middle phalanges of toes 2–5 (fig. 3D,
3H, 3L, and 3P) and very marked short middle phalanges
of the 5th finger (fig. 3B, 3F, 3J, and 3N). Combined short-
ening of the middle phalanges was noticed, with patterns
2–5 (3 patients), 2-4-5 (3 patients), and 2-3-4-5 (2 patients),
which indicates that the 2nd and 5th fingers are most
severely affected (fig. 3B, 3F, 3J, and 3N). In many cases,
the shortened middle phalanges were fused with the distal
ones (fig. 3B, 3F, 3J, and 3N). In 12 patients, radiographs
also showed very pronounced shortening of metacarpal
5, either alone or in combination with metatarsal 5 and/
or other metacarpals/metatarsals (fig. 3B, 3D, 3F, 3H, 3J,
3L, 3N, and 3P). Short proximal phalanges of toes 1, 3,
and 4 were apparent in 7 patients (fig. 3H, 3L, and 3P).
Other common limb anomalies included broad first met-
atarsals and hallux phalanges, often associated with hallux
valgus (fig. 3C, 3D, 3G, 3H, 3K, 3L, 3O, and 3P). Notably,
the proband also had small spurs of bone between the 1st
and 2nd metatarsals (fig. 3D). Almost all limb anomalies
in this family were bilateral. These limb phenotypes over-
lap with those of BDA4, BDD, and BDE, and syndactyly
type I (MIM %185900). No family member showed short
stature or polydactyly.
Molecular genetics.—We performed two-point linkage
analysis and mutation identification after obtaining in-
formed consent from participating family members and
approval of Peking Union Medical College Institutional
Review Board. Blood samples were collected and genomic
DNA was extracted from 27 members of family 1, includ-
ing 13 patients, and from 43 family members of family
2, including 15 patients. Six polymorphic microsatellite
markers from chromosome region 2q24.3-q32.1, includ-
ing a CA-repeat sequence within the intron of the HOXD13
gene, were selected and typed in the families, for two-
point linkage analysis. LOD scores were calculated using
the MLINK program of the LINKAGE package. The param-
eters used in linkage analysis were autosomal dominant
inheritance, complete penetrance, a mutation rate of zero,
equal male-female recombination rate, equal microsat-
ellite-allele frequency, and a disease-allele frequency of 1
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Figure 1. Pedigrees and disease-haplotype segregation of family 1 (A) and family 2 (B). Blackened symbols represent affected individuals
with abnormal limb phenotype, and unblackened symbols represent individuals with a normal limb phenotype. Circles and squares
indicate females and males, respectively. The arrows identify the probands. The disease haplotype is boxed.
in 10,000. Maximal LOD scores of 4.90 in family 1 and
of 6.46 in family 2 were obtained for marker D2S2314
at , showing definitive evidence of linkage. Hap-vp 0.00
lotype analysis indicated no recombination at five ge-
netic markers (D2S2981, D2S2314, D13-CA, D2S324, and
D2S1391) in family 1 (fig. 1A) and 3 markers (D2S2981,
D2S2314, and D13-CA) in family 2 (fig. 1B), indicating
that the disease locus was linked to the chromosome re-
gion harboring HOXD13. We searched for pathogenic mu-
tations in the proband of family 1 by direct sequencing
of the PCR-amplified DNA fragments spanning exons 1
and 2 of HOXD13. We identified a missense mutation,
c.950ArG (p.Q317R), substituting an arginine (R) for the
highly conserved Q50, which is important for DNA-bind-
364 The American Journal of Human Genetics Volume 80 February 2007 www.ajhg.org
Figure 2. Photographs and radiographs of the proband (A–D), individual V-10 (E–H), individual V-13 (I–L), and individual IV-10 (M–
P) of family 1.
ing specificity and affinity (fig. 4A). To confirm this mis-
sense mutation, we introduced into the 950G mutant al-
lele a BamHI recognition sequence (5′-GGATCC-3′), using
a mismatch primer (5′-CTTGTCCTTCACTCTTCGGATC-
3′) in a semi-nested PCR. Restriction analysis with use of
this BamHI site in all available members from family 1
and in 136 unrelated control individuals of similar ethnic
background revealed the presence of the mutation in all
affected individuals but not in unaffected family members
and control individuals (fig. 4A). In the proband of family
2, we sequenced the entire HOXD13 gene, including a pro-
moter region of 1.5 kb, two exons, one intron, two UTRs
(5′-UTR and 3′-UTR), and the coding exons of HOXD9
(GenBank accession number NM_014213), HOXD10 (Gen-
Bank accession number NM_002148), HOXD11 (GenBank
accession number NM_021192), and HOXD12 (GenBank
accession number NM_021193). We found a deletion of
21 bp in the imperfect GCN triplet–repeat sequence of
HOXD13 exon 1, c.157_177del, which results in a poly-
alanine contraction of seven residues (p.A53_A59del) (fig.
4B). By polyacrylamide gel electrophoresis, it was con-
firmed that this deletion cosegregated with the limb phe-
notypes in affected individuals but was not detected in
any unaffected individuals of the family or in 500 unre-
lated Han Chinese control individuals. A 4-alanine con-
traction was detected in the control individuals, with
an allele frequency of 0.3% (3 in 1,000). We also identi-
fied a novel missense mutation in HOXD11—c.734GrA
(p.G245D)—on the same chromosome that carries the 7-
alanine contraction mutation in HOXD13. This HOXD11
mutation was detected in 2 of 139 unrelated Han Chinese
control individuals.
Functional study.—We conducted the luciferase reporter
assay to determine the consequences of the p.Q317R sub-
stitution in transactivating the promoter of EPHA7 (Gen-
Bank accession number NM_004440), one of the direct
downstream target genes of HOXD13 during limb devel-
opment.29 The p.I314L and p.Q317R mutations in HOXD13
change the amino acids at the 47th and 50th residues of
the homeodomain, respectively. “I47L” had been used else-
where to designate the p.I314L mutation.25 Similarly, we
named the mutant HOXD13 with the p.Q317R substitu-
tion “Q50R.” The human EPHA7 promoter of 660 bp (from
580 to 80), which contains an HOXD13-binding site
ATATTATGG, was obtained by PCR from human genomic
DNA through use of primers EPHA7BamF 5′-CGCGGA-
TCCTGTTCGCTCGCACCGT-3′ and EPHA7R 5′-AGACTTC-
CTTTCCCACTCCC-3′. The amplified fragment was cloned
into the pGL3-basic vector (Promega) at the BglII and KpnI
sites upstream of the firefly luciferase gene and was verified
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Figure 3. Photographs and radiographs of the proband (A–D), individual III-10 (E–H), individual IV-19 (I–L), and individual IV-23
(M–P) of family 2.
by sequencing (fig. 5A). To make the expression vectors
for FLAG-HOXD13WT (the FLAG-tagged wild type) and
FLAG-HOXD137A (the FLAG-tagged mutant with the 7-
alanine contraction), the full coding regions were gener-
ated by genomic PCR from normal and affected individ-
uals, respectively. The verified fragments were then cloned
into the HindIII and SmaI sites of the p3#FLAG-CMV-
7 plasmid (Sigma), to produce the pFLAG-HOXD13WT
and pFLAG-HOXD137A expression vectors, respectively.
pFLAG-HOXD13Q50R and pFLAG-HOXD13I47L were con-
structed from the pFLAG-HOXD13WT by site-directed mu-
tagenesis with use of the QuikChange Site-Directed Mu-
tagenesis Kit (Stratagene). The primer pairs used were 5′-
CCATTTGGTTTCGGAACCGAAGAGTG-3′ and 5′-CACTC-
TTCGGTTCCGAAACCAAATGG-3′ for Q50R and 5′-GACA-
AGTGACCCTTTGGTTTCAG-3′ and 5′-CTGAAACCAAAGG-
GTCACTTGTC-3′ for I47L. The reporter construct (1.0 mg)
was cotransfected with 1.5 mg of one of the four test con-
structs (pFLAG-HOXD13WT, pFLAG-HOXD13Q50R, pFLAG-
HOXD13I47L, or pFLAG-HOXD137A) into the C3H10T1/2
mouse embryonic fibroblast cells growing in a 12-well
plate, with use of 1.0 ml VigoFect reagent (Vigorous Bio-
technology). The pRL-SV40 Renilla luciferase vector (25
ng) was also added in each cotransfection, to normalize
the transfection efficiency. Cells were lysed and assayed
for luciferase activity following the Dual Luciferase pro-
tocol (Promega). Consistent with the recent findings that
the mouse EphA7 promoter could mediate transcriptional
activation by HOXD13, expression of the human wild-
type HOXD13WT could also transactivate the human
EPHA7 promoter (fig. 5B).29 However, a remarkable dif-
ference in the decrease of transactivation between the
HOXD13Q50R and HOXD13I47L mutants was observed (fig.
5B and 5C). Q50R more severely impaired HOXD13′s ca-
pacity to transactivate the human EPHA7 promoter, re-
taining only 13% of the reporter activity compared with
the wild-type counterpart, whereas I47L showed merely
moderate impairment, with 63% of reporter activity re-
maining (fig. 5C). The polyalanine contraction of seven
residues seemed to exert no significant effect on HOXD13-
induced transactivation (fig. 5B and 5C). Cotransfection
of pFLAG-HOXD13WT and pFLAG-HOXD137A showed no
significant change in transcriptional activity (data not
shown).
Molecular modeling.—We modeled the interaction be-
tween the Q50R-mutant HOXD13 and DNA on the basis
of the crystal structure of Drosophila melanogaster antenna-
pedia (antp) homeodomain (Protein Data Bank ID 9ANT)
bound to DNA (fig. 6A). The Antp/DNA complex (PDB ID:
9ANT) was used as template for the modeling experi-
ments.30 I47 and Q50 of the homeodomain are identical
in 9ANT and HOXD13. The base corresponding to the 3′-
thymidine (Thy) in the core DNA consensus sequence 5′-
TAAT-3′ is Thy221 in 9ANT. To study the role of residues
47 and 50 of the HOXD13 homeodomain and the inter-
acting base (Thy), four models in the protein-DNA inter-
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Figure 4. HOXD13 missense and polyalanine contraction mutations in study families. A, Genomic DNA sequencing demonstrating the
presence and consequence of the missense mutation c.950ArG (p.Q317R) in the proband of family 1. BamHI restriction analysis
demonstrates segregation of the mutation, shown as a 249-bp fragment, with the disease phenotype in the family. B, Genomic DNA
sequencing demonstrating the presence and consequence of small deletion c.157-177del (p.A53_A59del) in the proband of family 2.
face were generated in silico (with the programs QUANTA
[Accelrys] and Program O31) from the crystal structure, to
mimic the different interactions. Two amino acids were
mutated in the homeodomain: I47rleucine (L) and Q50r
arginine (R). The backbone conformation was not altered.
The molecules were placed in a box containing 6,400
water molecules. All calculations were performed with
NAMD32 with use of the CHARMM33 force field. To cal-
culate the electrostatic interactions, a cutoff of 0.20 nm
was used. The energy of the structures was minimized by
75,000 steps by use of the conjugated gradient and line-
search algorithm of NAMD. Previous NMR and molecular
dynamics studies have shown the dynamic, fluctuating
nature of the protein-DNA interactions.34,35 Therefore, the
complete homeodomain and the DNA were allowed to
move during the minimization, to relax the entire struc-
ture and to ensure more-reliable calculations. To study the
local influence of mutations, only the interaction energies
between the pairs Q/R (I/L) and Thy were calculated with
NAMD and the CHARMM force field, respectively. Draw-
ings were prepared with PyMOL (DeLano Scientific) and
VMD.36 In an attempt to estimate the differences among
the models, the interaction energy was calculated for each
of the combinations of amino acid and base. The differ-
ence in the energies for the Q50R mutation was not as
small as in the I47L mutation (fig. 6B). The van der Waals
interactions were of the same order for both mutations,
which suggests that the change in the steric hindrance
was not significant. The electrostatic contribution to the
interaction showed a significant difference for both muta-
tions. The lower energy interaction between R50 and Thy
(RT in fig. 6B), as compared with Q50 and Thy (QT in fig.
6B) in the model, was consistent with the observed loss
of the transcriptional activity: to 13%, with respect to the
wild type (fig. 5C). The difference in the interaction energy
for the I47L mutation was small compared with that of
the Q50R mutation (fig. 6B). This was consistent with the
in vitro experimental results, which showed an average
activity of 63% (fig. 5C).
We have identified the disease-causing mutations respon-
sible for syndactyly type V and for a novel brachydactyly-
syndactyly syndrome, which extends the phenotypic spec-
trum associated with different mutations in HOXD13. We
propose the term “HOXD13 limb morphopathies” for all
limb malformations due to HOXD13 mutations, currently
including typical SPD caused by various polyalanine ex-
pansions,4,12–17 atypical SPD caused by four intragenic de-
letions and p.R298W,18–21 BDD/BDE caused by p.S308C,24
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Figure 5. Transcriptional activity of wild-type and mutant HOXD13
proteins at the human EPH7A promoter. A, Schematic diagram of
the reporter construct used in transfection assays. B, Transcrip-
tional activity mediated by HOXD13WT, HOXD13Q50R, HOXD13I47L, and
HOXD137A. Bars represent firefly/Renilla luciferase ratios for the
different constructs. Values are the means (SEM) of eight in-
dependent experiments. The significance of differences in expres-
sion was calculated using the independent-samples T test. P values
are presented above the bars. C, Relative decrease of transcrip-
tional activity mediated by mutant HOXD13 proteins compared with
the wild-type HOXD13WT.
BDE with mild SPD caused by p.I314L,24,25 syndactyly type
V caused by p.Q317R, and BDA4/BDD/BDE with mild 2–
3 toe syndactyly caused by a polyalanine contraction.
Syndactyly type V, as a distinct entity, has 4–5 meta-
carpal synostosis, a cardinal feature distinguishing it from
other nonsyndromic syndactylies.27,28 Study of family 1, a
6-generation Chinese family affected with this rare limb
malformation, enabled us to map the disease locus to the
chromosomal region where HOXD13 is located. In this
Han Chinese family, we identified a missense mutation of
HOXD13—c.950ArG (p.Q317R)—that substituted the ba-
sic and charged polar amino acid R for the uncharged polar
Q at the 50th residue of the homeodomain (Q50). This
mutation was found to cosegregate with the disease phe-
notype in the large family but not was present in any
unaffected family members or in 136 normal Han Chinese
control individuals. Q50 of the homeodomain is invari-
ant in all known HOX proteins (Homeodomain Resource)
and has been shown to be a key amino acid for DNA-
binding specificity and affinity.5–10,37 Moreover, our func-
tional study showed that the mutation had a deleterious
effect on HOXD13-induced transcriptional activation of
the human EPHA7 promoter. Finally, molecular modeling
data supported the in vitro experimental results. All these
results established conclusively the pathogenicity of the
c.950ArG (p.Q317R) mutation in syndactyly type V.
SPD was the first disease in which polyalanine expan-
sion was identified as the disease-causing mechanism.12
This novel type of mutation has been found in nine dif-
ferent human genetic diseases.38–40 Like HOXD13 in SPD,
polyalanine expansions in these genetic diseases show mei-
otic stability over generations, distinguishing it from dy-
namic triplet-repeat expansions underlying genetic dis-
eases such as Huntington disease and fragile X syndrome.
Unequal crossing-over has been suggested as the mecha-
nism for polyalanine expansion.41 Polyalanine contrac-
tion, the reciprocal allele of this unequal crossing-over,
has not previously been associated with a human genetic
disease,39 although Dr. Stephen T. Warren has predicted
that the mutant HOXD13 alleles with truncated polyalan-
ine tracts of fewer than eight residues “might lead to other
digital anomalies.”41(p408) In the large Han Chinese family
affected with combined BDA4/BDD/BDE and mild 2–3 toe
syndactyly, we mapped the disease locus to a chromosome
region defined by D2S1379 and D2S324 (fig. 1B). This re-
gion contains 170 known genes, including the 9 HOXD
genes (Human Genome Browser Gateway). We sequenced
all the 5′ HOXD genes that show expression in the limb
bud42 and found a polyalanine contraction of seven resi-
dues in HOXD13 that segregated perfectly with the digital
anomalies. The contraction was not detectable in 500 un-
related and ethnically matched unaffected control indi-
viduals. The site and length of the polyalanine tract in
HOXD13, like that in the paralogous HOXA13, are highly
conserved among mammals.43 All mammalian HOXD13
proteins with sequences available in the databases—in-
cluding human, chimpanzee, mouse, rat, and bat—have
a 15-residue polyalanine tract in their N-terminal region,
which suggests a strong functional and structural con-
straint. It has been indicated that a polyalanine tract be-
yond a certain threshold will have deleterious effects.40
Mutations in HOXD13 have been associated with BDD and
BDE, whereas mild 2–3 toe syndactyly is common in in-
dividuals heterozygous for a 7-alanine expansion muta-
tion in HOXD13.13,24 Furthermore, homozygous mouse
mutants with the disrupted Hoxd13 gene showed absence
of the second phalanges in digits II and V, size reduction
of the second phalanges in digits III and IV, deformed and
thicker metatarsal I with anterior protrusion, and short-
ened metacarpals and metatarsals in both of the forelimbs
and the hindlimbs.44,45 These, taken together, suggested
that the 7-alanine contraction mutation in HOXD13 was
most likely responsible for the novel brachydactyly-syn-
dactyly syndrome. In unaffected individuals, other re-
searchers have detected 2- and 4-alanine contractions in
HOXD13.16,46 In our Han Chinese control individuals, the
4-alanine contraction reported46 elsewhere in the Japanese
population was detected as a very rare allele. Several other
genes with pathogenic polyalanine expansions also dis-
play polyalanine tract-length polymorphisms—that is, ex-
pansions and contractions—in the general population.39,-
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Figure 6. Interaction between HOXD13 and DNA. A, Models based on the Antp/DNA complex. The DNA is color coded as follow: carbon
p cyan; oxygenp red; nitrogenp dark blue; phosphatep gold. For the helix III of the homeodomain, the main chain is represented,
and only the side chains of the I47 and Q50 (left panel) and of the I47 and R50 (right panel) are drawn. B, Total (red line), electrostatic
(blue line), and van der Waals (green line) interactions energies (in kcal/mol) between Q50 and Thy (wild type) and between R50 and
Thy (mutant) (left panel) and between I47 and Thy (wild type) and L47 and Thy (mutant) (right panel). The numbers 47 and 50 represent
the position of the amino acid in the homeodomain.
47 Therefore, polyalanine contraction of fewer than seven
residues in HOXD13, as in the case of polyalanine ex-
pansion, might represent polymorphisms and might not
be pathogenic. Noticeably, a novel missense mutation in
HOXD11 (c.734GrA), substituting the acidic aspartate (D)
for the nonpolar glycine (G) at residue 245 (p.G245D),
was found in all affected individuals in the family. This
substitution was also detected in unaffected controls. In
mice and chickens, digit I identity was assumed to be
Hoxd13 positive and Hoxd12/Hoxd11 negative.48 Affected
individuals in family 2, however, frequently showed de-
formed thumbs and halluces (digit I). Moreover, the hind-
limbs of Hoxd11/ mice showed no major defects, al-
though the forelimbs displayed a strong reduction in
length of the second phalanges in digits II and V and
shortened metacarpals.49 Therefore, the missense muta-
tion in HOXD11 might represent a rare polymorphism.
HOXD13 limb morphopathies cover several distinctive
sets of limb malformations with different pathogenicmech-
anisms. Studies of mice (Hoxd13//Hoxd12//Hoxd11/
knockout and spdh mutant), mammalian cells, and clinical
SPD cases have suggested a “super” dominant negative
effect as the pathogenic mechanism underlying typical
SPD.13,16,50–52 Molecular analysis of different families has
indicated that loss-of-function mutations in HOXD13 lead
to atypical SPD.18–21 Recently, Hoxd13 has been shown to
be a regulator of EphA7 during limb development.29 Both
human HOXD13 and mouse Hoxd13 can directly bind to
a regulatory element within the EphA7 promoter. Ectopic
expression of HOXD13 in mouse cells can activate tran-
scription of the endogenous EphA7 gene and transactivate
the EphA7 promoter in a reporter construct. In contrast,
the mutant HOXD13 with I47L does not bind to the reg-
ulatory element and induces only a minor transactivation
of the EphA7 promoter.29 The syndactyly type V described
in our present report and the work of Robinow et al.28 had
a common limb feature with atypical SPD: hyperplasia of
the 1st ray in feet displayed as unusually broad hallux
phalanges and first metatarsals.28 Using a luciferase re-
porter construct containing the human EPHA7 promoter,
we showed that Q50R exerted much more severe impair-
ment in HOXD13-induced transactivation and that the
HOXD13I47L mutant retained considerable activity, which
suggests a complete loss of function for HOXD13Q50R and
a partial loss of function for HOXD13I47L in regulation of
EPHA7, respectively. The difference in transactivation pro-
vided a molecular basis for the different limb phenotypes
produced by these two mutations. However, metacarpal
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fusions in syndactyly type V could be a gain-of-function
effect, because this limb phenotype was absent both in
patients with atypical SPD and in Hoxd13 knockout
mice.4,12–17,44,45 It has been demonstrated elsewhere9,10 that
Q50 is an important determinant of differential DNA-
binding specificity among different homeodomains. A sin-
gle amino acid substitution to the basic and charged polar
lysine (K) could switch the DNA-binding specificities of
different homeodomains.9,10 Guttmacher syndrome (MIM
176305) shares some phenotypes with hand-foot-genital
syndrome (MIM 140000), which is caused by loss-of-func-
tion mutations in HOXA13.53 In patients affected with
Guttmacher syndrome, the p.Q371L missense mutation
was identified.54 This mutation led to a substitution at Q50
of the HOXA13 homeodomain. The presence of additional
limb phenotypes in Guttmacher syndrome suggested that
the amino acid substitution resulted in both a loss and
specific gain of function.54 It is conceivable that a mixed
gain and loss of function of HOXD13Q50R is a reasonable
explanation of the cause of syndactyly type V. The poly-
alanine contraction found in the family with BDA4/
BDD/BDE and mild 2–3 toe syndactyly is more likely a
dominant-negative mutation, since Hoxd13/ mice have
similar phalangeal and metacarpal/metatarsal defects.44,45
Transheterozygous Hoxd13//Hoxd12/ mice also exhibit
a reduction of digits II and V in the forelimbs.44 Further-
more, hypoplasia of the middle phalanges of toes 2–5 and
broad hallux phalanges and first metatarsals are consistent
in atypical SPD associated with functional haploinsuffi-
ciency for the homeodomain of HOXD13.18–21 However,
our reporter assay showed no significant difference be-
tween HOXD13WT and HOXD137A in regulation of EPHA7.
Mutant HOXD13 proteins with polyalanine tracts longer
than 22 residues displayed misfolding and cytoplasmic
aggregation.40 We observed that the GFP-tagged HOXD13
proteins with different polyalanine contractions were all
located in the nucleus (data not shown). Polyalanine tracts
are common in transcription factors and may modulate
transcriptional regulation and protein-protein interac-
tion.38,47 Interestingly, longer polyalanine tracts (110 ala-
nines) formed b-sheet, whereas shorter ones (7 alanines)
adopted a-helix exclusively.55 It is possible that the 7-al-
anine contraction in HOXD13 could perturb its binding
to the cofactors or trigger a rapid protein processing.
Our present report and the observations of others all
indicate the existence of genotype-phenotype correlation
for the limb morphopathies caused by HOXD13 muta-
tions.11,13,16,24 However, the same minor malformations
may be associated with the different limb clinical abnor-
malities—for example, (1) soft-tissue syndactyly of toes
2 and 3 in mild SPD due to a polyalanine expansion of
seven residues, in the brachydactyly-syndactyly syndrome
caused by a polyalanine contraction of seven residues, and
in syndactyly type V, and (2) cutaneous syndactyly of fin-
gers 3 and 4 without digit duplication within the web in
mild SPD and syndactyly type V. Therefore, different limb
malformations due to distinct classes of HOXD13 muta-
tions should be considered a continuum of phenotypes.
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